Menu

Growing Placenta-Generating Cells

Researchers derive trophoblast stem cells from mouse fibroblasts, paving the way for cell therapy for placental dysfunction diseases.

Oct 14, 2015
Jef Akst

High-magnification micrograph of intermediate trophoblast cellsWIKIMEDIA, NEPHRONTransiently expressing three genes in mouse fibroblasts, an international team of researchers has coaxed the cells into trophoblast stem-like cells (TSCs), skipping a pluripotent stage. The derived cells had similar characteristics to blastocyst-derived TSCs—which form most of the developing placenta—and contributed to placental cell lineages in vitro, according to a study published last month (September 24) in Cell Stem Cell.

“Here, we describe a method to generate stable and fully functional TSC-like cells from murine fibroblasts by transient ectopic expression of three TSC key master regulators, Gata3, Eomes, and Tfap2c,” the authors wrote in their paper. “These data suggest that the conversion of fibroblasts into iTSCs represents a very high degree of nuclear reprogramming and refute the hypothesis that complete nuclear reprogramming can be achieved only in cells undergoing conversion to ESC-like cells.”

“The success of this study will grant a real chance for women who suffer from placental dysfunction diseases to have healthy babies,” according to a press release. When the placenta does not develop properly or is damaged, the baby be born prematurely, have a low birth weight, or have other complications that can risk both the child’s and mother’s health. “To date, tools to model or treat these diseases are limited because all attempts to isolate and propagate the human placenta precursor cells . . . in the dish have failed.”

December 2018

Invisible Borders

An emerging appreciation for membraneless organelles and the liquid dynamics that shape them

Marketplace

Sponsored Product Updates

Using CDD Vault to Manage Redbrid Molecular Ltd. Catalogues - A Case Study
Using CDD Vault to Manage Redbrid Molecular Ltd. Catalogues - A Case Study
Check out this case study to find out why Redbrick Molecular Ltd. chose CDD Vault as their database and informatics platform, and how they made use of the CDD Vault to implement a complex catalogue in a simple way.
New automated N-glycan profiling web app shaves days off of data interpretation for glycobiologists
New automated N-glycan profiling web app shaves days off of data interpretation for glycobiologists
The first automated, web-based application that enables routine use of enzymatic digestions to improve N-glycan analyses from New England Biolabs (NEB). This software not only saves precious times for glycobiologists who are more attuned to traditional methods, but also provides the most accurate interpretation of glycan enzymatic digestion data on the market.
Recapitulating 3-D Microenvironments In Vitro Using Hollow Fiber Bioreactors
Recapitulating 3-D Microenvironments In Vitro Using Hollow Fiber Bioreactors
Download this white paper from FiberCell Systems to learn about how HFBRs are used in single cell-type/multi cell-type assays, antiviral and anticancer drug evaluations, and generating 3-D cellular models!
Using Centrifugal Ultrafiltration for Cloning and PCR
Using Centrifugal Ultrafiltration for Cloning and PCR
Learn about how centrifugal ultrafiltration devices can provide a more streamlined cloning process with this application note from PALL Laboratory!